Prescription Drugs-List Price, Net Price, and the Rebate Caught in the Middle
JAMA
.
2019 Apr 23;321(16):1563-1564.
doi: 10.1001/jama.2019.2445.
Authors
Stacie B Dusetzina
1
2
,
Peter B Bach
3
Affiliations
1
Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
2
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
3
Memorial Sloan Kettering Cancer Center, New York, New York.
PMID:
30840047
DOI:
10.1001/jama.2019.2445
No abstract available
MeSH terms
Drug Costs*
Drug Industry
Health Expenditures
Humans
Medicare Part D / economics*
Pharmacies / economics*
Prescription Drugs / economics*
Prescription Fees*
United States
Substances
Prescription Drugs